tiprankstipranks
Trending News
More News >
Palvella Therapeutics (PVLA)
NASDAQ:PVLA

Compare Palvella Therapeutics (PVLA) vs. Competitors

Compare
729 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Palvella Therapeutics
$99.73
$1.18B
-7.91
654.39%
15 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$20.01
$1.01B
35.57
137.09%
4 Buy
1 Hold
0 Sell
Strong Buy
Monopar Therapeutics Inc
$70.00
$467.78M
-20.36
129.66%
11 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$19.21
$1.95B
-6.48
-1.44%
15 Buy
1 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$36.60
$3.89B
-35.47
713.33%
10 Buy
0 Hold
0 Sell
Strong Buy
Tyra Bioscience
$28.77
$1.54B
-15.31
78.14%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PVLA
Palvella Therapeutics
99.73
86.53
655.53%
TBPH
Theravance Biopharma
20.01
10.86
118.69%
MNPR
Monopar Therapeutics Inc
70.00
38.32
120.96%
NRIX
Nurix Therapeutics
19.21
-0.39
-1.99%
TERN
Terns Pharmaceuticals
36.60
32.15
722.47%
TYRA
Tyra Bioscience
28.77
12.86
80.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts